Minerva Neurosciences
NERV
21 hedge funds and large institutions have $5.65M invested in Minerva Neurosciences in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.
236% more capital inflows, than outflows
Capital inflows: $130K | Capital outflows: $38.8K
0.45% more ownership
Funds ownership: 29.85% → 30.3% (+0.45%)
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$50.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$30.6K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$24.1K |
| 4 |
UBS O'Connor
Chicago,
Illinois
|
+$21.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$30.5K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
| 3 |
Tower Research Capital (TRC)
New York
|
-$1.57K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$326 |
| 5 |
Sandy Spring Bank
Olney,
Maryland
|
-$319 |
NERV Hedge Fund Activity: Q3 2024 in Review
21 of the 6,987 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2024, worth a combined $5.65M — down 15% from $6.65M a quarter earlier.
Fund positioning in NERV was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $50.1K. The largest seller was Renaissance Technologies, cutting an estimated $30.5K.
- 21 institutional investors held Minerva Neurosciences (NERV) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $5.65M of Minerva Neurosciences stock for Q3 2024, down 15% quarter-over-quarter.
- 2 funds opened new Minerva Neurosciences positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Minerva Neurosciences buyer in Q3 2024 was Citadel Advisors, an estimated $50.1K added.
- The largest Minerva Neurosciences seller in Q3 2024 was Renaissance Technologies, an estimated $30.5K sold.
Based on aggregated 13F filings for Q3 2024.